285 related articles for article (PubMed ID: 16298986)
21. N-linked glycosylation of the HIV type-1 gp120 envelope glycoprotein as a major determinant of CCR5 and CXCR4 coreceptor utilization.
Pollakis G; Kang S; Kliphuis A; Chalaby MI; Goudsmit J; Paxton WA
J Biol Chem; 2001 Apr; 276(16):13433-41. PubMed ID: 11278567
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 co-receptor usage based on V3 loop sequence analysis: preferential suppression of CXCR4 virus post HAART?
Jiao Y; Wang P; Zhang H; Zhang T; Zhang Y; Zhu H; Wu H
Immunol Invest; 2011; 40(6):597-613. PubMed ID: 21513481
[TBL] [Abstract][Full Text] [Related]
23. A genotypic method for determining HIV-2 coreceptor usage enables epidemiological studies and clinical decision support.
Döring M; Borrego P; Büch J; Martins A; Friedrich G; Camacho RJ; Eberle J; Kaiser R; Lengauer T; Taveira N; Pfeifer N
Retrovirology; 2016 Dec; 13(1):85. PubMed ID: 27998283
[TBL] [Abstract][Full Text] [Related]
24. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
25. Neutralization profiles of primary human immunodeficiency virus type 1 isolates in the context of coreceptor usage.
Cecilia D; KewalRamani VN; O'Leary J; Volsky B; Nyambi P; Burda S; Xu S; Littman DR; Zolla-Pazner S
J Virol; 1998 Sep; 72(9):6988-96. PubMed ID: 9696790
[TBL] [Abstract][Full Text] [Related]
26. Relationships between CD4 independence, neutralization sensitivity, and exposure of a CD4-induced epitope in a human immunodeficiency virus type 1 envelope protein.
Edwards TG; Hoffman TL; Baribaud F; Wyss S; LaBranche CC; Romano J; Adkinson J; Sharron M; Hoxie JA; Doms RW
J Virol; 2001 Jun; 75(11):5230-9. PubMed ID: 11333905
[TBL] [Abstract][Full Text] [Related]
27. The role of the humoral immune response in the molecular evolution of the envelope C2, V3 and C3 regions in chronically HIV-2 infected patients.
Borrego P; Marcelino JM; Rocha C; Doroana M; Antunes F; Maltez F; Gomes P; Novo C; Barroso H; Taveira N
Retrovirology; 2008 Sep; 5():78. PubMed ID: 18778482
[TBL] [Abstract][Full Text] [Related]
28. Coreceptor utilization of HIV type 1 subtype E viral isolates from Thai men with HIV type 1-infected and uninfected wives.
Utaipat U; Duerr A; Rudolph DL; Yang C; Butera ST; Lupo D; Pisell T; Tangmunkongvorakul A; Kamtorn N; Nantachit N; Nagachinta T; Suriyanon V; Robison V; Nelson KE; Sittisombut N; Lal RB
AIDS Res Hum Retroviruses; 2002 Jan; 18(1):1-11. PubMed ID: 11804551
[TBL] [Abstract][Full Text] [Related]
29. Humoral Immune Pressure Selects for HIV-1 CXC-chemokine Receptor 4-using Variants.
Lin N; Gonzalez OA; Registre L; Becerril C; Etemad B; Lu H; Wu X; Lockman S; Essex M; Moyo S; Kuritzkes DR; Sagar M
EBioMedicine; 2016 Jun; 8():237-247. PubMed ID: 27428434
[TBL] [Abstract][Full Text] [Related]
30. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
Bures R; Morris L; Williamson C; Ramjee G; Deers M; Fiscus SA; Abdool-Karim S; Montefiori DC
J Virol; 2002 Mar; 76(5):2233-44. PubMed ID: 11836401
[TBL] [Abstract][Full Text] [Related]
31. Small amino acid changes in the V3 loop of human immunodeficiency virus type 2 determines the coreceptor usage for CXCR4 and CCR5.
Isaka Y; Sato A; Miki S; Kawauchi S; Sakaida H; Hori T; Uchiyama T; Adachi A; Hayami M; Fujiwara T; Yoshie O
Virology; 1999 Nov; 264(1):237-43. PubMed ID: 10544150
[TBL] [Abstract][Full Text] [Related]
32. Characterization of V3 sequence heterogeneity in subtype C human immunodeficiency virus type 1 isolates from Malawi: underrepresentation of X4 variants.
Ping LH; Nelson JA; Hoffman IF; Schock J; Lamers SL; Goodman M; Vernazza P; Kazembe P; Maida M; Zimba D; Goodenow MM; Eron JJ; Fiscus SA; Cohen MS; Swanstrom R
J Virol; 1999 Aug; 73(8):6271-81. PubMed ID: 10400718
[TBL] [Abstract][Full Text] [Related]
33. Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India.
Makhdoomi MA; Singh D; Nair Pananghat A; Lodha R; Kabra SK; Luthra K
Virology; 2016 Dec; 499():105-113. PubMed ID: 27643887
[TBL] [Abstract][Full Text] [Related]
34. Determinants of CD4 independence for a human immunodeficiency virus type 1 variant map outside regions required for coreceptor specificity.
LaBranche CC; Hoffman TL; Romano J; Haggarty BS; Edwards TG; Matthews TJ; Doms RW; Hoxie JA
J Virol; 1999 Dec; 73(12):10310-9. PubMed ID: 10559349
[TBL] [Abstract][Full Text] [Related]
35. The evolution of human immunodeficiency virus type-1 (HIV-1) envelope molecular properties and coreceptor use at all stages of infection in an HIV-1 donor-recipient pair.
Edo-Matas D; Rachinger A; Setiawan LC; Boeser-Nunnink BD; van 't Wout AB; Lemey P; Schuitemaker H
Virology; 2012 Jan; 422(1):70-80. PubMed ID: 22047989
[TBL] [Abstract][Full Text] [Related]
36. V2 loop glycosylation of the human immunodeficiency virus type 1 SF162 envelope facilitates interaction of this protein with CD4 and CCR5 receptors and protects the virus from neutralization by anti-V3 loop and anti-CD4 binding site antibodies.
Ly A; Stamatatos L
J Virol; 2000 Aug; 74(15):6769-76. PubMed ID: 10888615
[TBL] [Abstract][Full Text] [Related]
37. Evidence that antibody-mediated neutralization of human immunodeficiency virus type 1 by sera from infected individuals is independent of coreceptor usage.
Montefiori DC; Collman RG; Fouts TR; Zhou JY; Bilska M; Hoxie JA; Moore JP; Bolognesi DP
J Virol; 1998 Mar; 72(3):1886-93. PubMed ID: 9499040
[TBL] [Abstract][Full Text] [Related]
38. Genetic characteristics of the V3 region associated with CXCR4 usage in HIV-1 subtype C isolates.
Coetzer M; Cilliers T; Ping LH; Swanstrom R; Morris L
Virology; 2006 Dec 5-20; 356(1-2):95-105. PubMed ID: 16942785
[TBL] [Abstract][Full Text] [Related]
39. V3-specific polyclonal antibodies affinity purified from sera of infected humans effectively neutralize primary isolates of human immunodeficiency virus type 1.
Krachmarov CP; Kayman SC; Honnen WJ; Trochev O; Pinter A
AIDS Res Hum Retroviruses; 2001 Dec; 17(18):1737-48. PubMed ID: 11788025
[TBL] [Abstract][Full Text] [Related]
40. V3 loop-determined coreceptor preference dictates the dynamics of CD4+-T-cell loss in simian-human immunodeficiency virus-infected macaques.
Ho SH; Shek L; Gettie A; Blanchard J; Cheng-Mayer C
J Virol; 2005 Oct; 79(19):12296-303. PubMed ID: 16160156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
